NAD+ Booster Formula is a dietary supplement that combines the 3 most effective nutrients associated with the production of NAD+, a coenzyme essential to cellular vitality and longevity.
It has been designed to support people who want to maintain their NAD+ levels, which start to decline from their thirties and may fall by as much as 20% by their sixties.
This innovative product is listed in our longevity category.
Composition and benefits of our NAD+ 'booster' food supplement
Role of NAD+ in cell energy and longevity
Nicotinamide adenine dinucleotide (NAD) is a coenzyme present in all the body's cells.
In its oxidised form, called NAD+, it is known to:
-
participate in the production of ATP, the main source of energy for cells, by transferring electrons during cellular respiration;
-
activate sirtuins, enzymes involved in cell longevity;
-
be essential for PARP enzymes, which repair DNA (1-2).
With age and oxidative stress, the activity of sirtuins and PARP increases to repair cells, while the level of the CD38 enzyme, which degrades NAD+, rises sharply.
This process reduces NAD+ levels.
When NAD+ is insufficient, and energy production (ATP) remains the priority, sirtuins and PARP enzymes function at a slower pace, accelerating cellular senescence and ageing (3-6).
Benefits of the 3 ingredients in NAD+ Booster Formula
Our exceptional supplement contains a trio of ingredients studied for their link with NAD+ production:
-
nicotinamide riboside (NR): NR is a form of vitamin B3 (niacin) that contributes to normal energy metabolism, fatigue reduction and normal nervous system function. Nicotinamide riboside is reputed to be one of the most effective precursors of NAD. In addition to being particularly bioavailable, it disperses minimally into other metabolic pathways, unlike simple nicotinamide. More specifically, our supplement uses nicotinamide riboside chloride, the most stable and pure form of NR. Numerous studies suggest that consumption of nicotinamide riboside increases NAD levels in various tissues (7-18);
-
Apigenin: apigenin is a flavonoid naturally present in certain plants, such as parsley, oregano and tea. Here, it comes from a celery leaf extract standardised to 42% apigenin. Several studies have found that this compound could inhibit the activity of CD38, the enzyme primarily responsible for breaking down NAD+ (19-20);
-
BluNAD Booster™, a proprietary botanical blend of pomegranate fruit rind extract (Punica granatum) and tagetes flower extract (Tagetes erecta): this innovative botanical combination was the subject of a randomised, double-blind, placebo-controlled clinical study conducted on 140 subjects for 60 days at 1,000 mg/day. The study revealed the possible efficacy of the compound in neutralising CD38 activity (-18%) and increasing NAD+ levels (+26.3%). BluNAD Booster™ is even more effective at increasing NAD+ levels than NR or other precursors taken alone. Its combination with NR (500 mg/per day of BluNAD Booster™ and 500 mg/per day of NR) has also been judged to be the most promising synergy for increasing the amount of NAD+ in the body (+31.4%) (21).
Study findings on the potential ability of BluNAD Booster™ to raise NAD+ levels (21).
4 strong points of the pro-longevity NAD+ Booster Formula
NAD+ Booster Formula has 4 key strengths:
-
an exclusive synergy: our formula is the only one to combine these 3 super-powerful ingredients, extensively studied in the field of cellular energy and longevity, with NR, celery apigenin and the innovative BluNAD Booster™ blend;
-
an exceptional dose of nicotinamide riboside: we have increased the dose of nicotinamide riboside chloride to 300 mg per day to guarantee optimal effects;
-
a cutting-edge compound that has been the subject of clinical studies: the particularly innovative BluNAD Booster™ brand ingredient has had its properties clinically tested, with remarkable results;
-
vegetable capsules with natural excipients: the vegan capsules used are made from hypromellose (HPMC), a compound derived from cellulose, and contain acacia gum, a vegetable ingredient, as their sole excipient.
Daily dose: 3 capsules
Number of doses per box: 30
|
Daily dose
|
BluNAD Booster™
Exclusive blend of Punica granatum fruit peel extract and Tagetes erecta flower extract.
|
500 mg
|
Nicotinamide riboside chloride
|
300 mg
|
Apigenin
Celery leaf extract standardised to 42% apigenin
|
50 mg
|
Other ingredients: hypromellose capsule, acacia gum.
BluNAD Booster™ is a registered trademark of Blue Helix Health.
|
Recommended amount: take 3 capsules a day with meals.
Duration: 30 days.
Storage: conventional storage away from heat, light and moisture.
Watch out: not recommended for pregnant or breastfeeding women. As with any dietary supplement, consult a health professional before use if you have a health problem.
Precautions: adults only. Do not exceed the recommended daily dose. This product is a dietary supplement and should not be used as a substitute for a varied, balanced diet or a healthy lifestyle.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021 Feb;22(2):119-141. doi: 10.1038/s41580-020-00313-x. Epub 2020 Dec 22. PMID: 33353981; PMCID: PMC7963035.
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014 Aug;24(8):464-71. doi: 10.1016/j.tcb.2014.04.002. Epub 2014 Apr 29. PMID: 24786309; PMCID: PMC4112140.
- McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Exp Gerontol. 2020 Feb 22;134:110888. doi: 10.1016/j.exger.2020.110888. Epub ahead of print. PMID: 32097708; PMCID: PMC7442590.
- Liu L, Su X, Quinn WJ 3rd, Hui S, Krukenberg K, Frederick DW, Redpath P, Zhan L, Chellappa K, White E, Migaud M, Mitchison TJ, Baur JA, Rabinowitz JD. Quantitative Analysis of NAD Synthesis-Breakdown Fluxes. Cell Metab. 2018 May 1;27(5):1067-1080.e5. doi: 10.1016/j.cmet.2018.03.018. PMID: 29685734; PMCID: PMC5932087.
- Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357. doi: 10.1371/journal.pone.0042357. Epub 2012 Jul 27. PMID: 22848760; PMCID: PMC3407129.
- Okabe K, Yaku K, Tobe K, Nakagawa T. Implications of altered NAD metabolism in metabolic disorders. J Biomed Sci. 2019 May 11;26(1):34. doi: 10.1186/s12929-019-0527-8. PMID: 31078136; PMCID: PMC6511662.
- Stock AJ, Ayyar S, Kashyap A, Wang Y, Yanai H, Starost MF, Tanaka-Yano M, Bodogai M, Sun C, Wang Y, Gong Y, Puligilla C, Fang EF, Bohr VA, Liu Y, Beerman I. Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo. Geroscience. 2023 Aug;45(4):2213-2228. doi: 10.1007/s11357-023-00752-2. Epub 2023 Feb 24. PMID: 36826621; PMCID: PMC10651621.
- Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018 Mar 29;9(1):1286. doi: 10.1038/s41467-018-03421-7. PMID: 29599478; PMCID: PMC5876407.
- Sun X, Cao B, Naval-Sanchez M, Pham T, Sun YBY, Williams B, Heazlewood SY, Deshpande N, Li J, Kraus F, Rae J, Nguyen Q, Yari H, Schröder J, Heazlewood CK, Fulton M, Hatwell-Humble J, Das Gupta K, Kapetanovic R, Chen X, Sweet MJ, Parton RG, Ryan MT, Polo JM, Nefzger CM, Nilsson SK. Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells. Nat Commun. 2021 May 11;12(1):2665. doi: 10.1038/s41467-021-22863-0. PMID: 33976125; PMCID: PMC8113506.
- Zhang H, Ryu D, Wu Y, Gariani K, Wang X, Luan P, D'Amico D, Ropelle ER, Lutolf MP, Aebersold R, Schoonjans K, Menzies KJ, Auwerx J. NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science. 2016 Jun 17;352(6292):1436-43. doi: 10.1126/science.aaf2693. Epub 2016 Apr 28. PMID: 27127236.
- Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions. J Gerontol A Biol Sci Med Sci. 2023 Dec 1;78(12):2435-2448. doi: 10.1093/gerona/glad106. PMID: 37068054; PMCID: PMC10692436.
- Mehmel M, Jovanović N, Spitz U. Nicotinamide Riboside-The Current State of Research and Therapeutic Uses. Nutrients. 2020 May 31;12(6):1616. doi: 10.3390/nu12061616. PMID: 32486488; PMCID: PMC7352172.
- Biţă A, Scorei IR, Ciocîlteu MV, Nicolaescu OE, Pîrvu AS, Bejenaru LE, Rău G, Bejenaru C, Radu A, Neamţu J, Mogoşanu GD, Benner SA. Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives. Molecules. 2023 Aug 15;28(16):6078. doi: 10.3390/molecules28166078. PMID: 37630330; PMCID: PMC10459282.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018 Mar 6;27(3):529-547. doi: 10.1016/j.cmet.2018.02.011. PMID: 29514064; PMCID: PMC6342515.
- Li Q, Jiang X, Zhou Y, Gu Y, Ding Y, Luo J, Pang N, Sun Y, Pei L, Pan J, Gao M, Ma S, Xiao Y, Hu D, Wu F, Yang L. Improving Mitochondrial Function in Skeletal Muscle Contributes to the Amelioration of Insulin Resistance by Nicotinamide Riboside. Int J Mol Sci. 2023 Jun 12;24(12):10015. doi: 10.3390/ijms241210015. PMID: 37373163; PMCID: PMC10297940.
- Wang L, Chen C, Zhou H, Tao L, Xu E. Nicotinamide Riboside-Driven Modulation of SIRT3/mtROS/JNK Signaling Pathways Alleviates Myocardial Ischemia-Reperfusion Injury. Int J Med Sci. 2024 Aug 12;21(11):2139-2148. doi: 10.7150/ijms.97530. PMID: 39239543; PMCID: PMC11373543.
- Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, Mattson MP, Croteau DL, Bohr VA. NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING. Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2011226118. doi: 10.1073/pnas.2011226118. PMID: 34497121; PMCID: PMC8449423.
- Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, Wang J, Sastre M, Ono K, Sauve AA, Pasinetti GM. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging. 2013 Jun;34(6):1581-8. doi: 10.1016/j.neurobiolaging.2012.12.005. Epub 2013 Jan 9. PMID: 23312803; PMCID: PMC3632303.
- Kramer DJ, Johnson AA. Apigenin: a natural molecule at the intersection of sleep and aging. Front Nutr. 2024 Feb 27;11:1359176. doi: 10.3389/fnut.2024.1359176. PMID: 38476603; PMCID: PMC10929570.
- Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O'Neil L, White TA, Sinclair DA, Chini EN. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 2013 Apr;62(4):1084-93. doi: 10.2337/db12-1139. Epub 2012 Nov 19. PMID: 23172919; PMCID: PMC3609577.
- Clinical study outcome for BluNR, BluNAD Booster A randomized, double-blind placebo-controlled clinical study to evaluate the effect of BluNAD Booster (LN22199), Nicotinamide Riboside (NR) and their combination on blood NAD levels in healthy older subjects.
- Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, Chonchol M, Seals DR. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018 Mar 29;9(1):1286. doi: 10.1038/s41467-018-03421-7. PMID: 29599478; PMCID: PMC5876407.